Loading company…
Peijia Medical Co., Ltd. of Suzhou, China develops high-end heart and cerebrovascular medical devices and was listed in Hong Kong in 2020.
Established in 2012 and based in Suzhou, China, Peijia Medical Co., Ltd. develops and produces medical devices for structural heart disease and cerebrovascular intervention, including aortic, mitral and tricuspid valves and intracranial coils. The company has applied for more than 400 patents and has innovation and R&D centers in the United States, Canada and France. In November 2019 it raised USD 100 million in Series C funding, and it was listed on the Hong Kong Stock Exchange in 2020.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in